Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rosetta Genomics Ltd ROSGQ

Healthcare Biotechnology Diagnostics & Research
Rosetta Genomics Ltd. is an Israel-based company engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA), and protein biomarkers, and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence... see more

Recent & Breaking News (GREY:ROSGQ)

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Rosetta Genomics Announces Agreement With Global Pharmaceutical Company to Advance Efforts in Alzheimer's Disease Diagnostics

eTeligis July 31, 2014

Rosetta Genomics Announces Next-Generation Sequencing Research Collaboration With Weizmann Institute of Science's Nancy and Stephen Grand Israel National Center for Personalized Medicine

eTeligis July 29, 2014

Rosetta Genomics Receives Final New York State Approval for Rosetta Kidney Cancer Test

eTeligis July 22, 2014

Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Treatment of Ovarian Cancer

eTeligis July 10, 2014

Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Prognosis and Treatment of Prostate Cancer

eTeligis June 26, 2014

UPDATE: Rosetta Genomics and Moffitt Cancer Center Enter Into Agreement to Advance Development of microRNA-Based Cancer Diagnostic

eTeligis June 9, 2014

Rosetta Genomics and Moffitt Cancer Center Enter Into Agreement to Advance Development of microRNA-Based Cancer Diagnostic

Marketwired June 9, 2014

Rosetta Genomics to Receive U.S. Patent for Cancer Origin Assay

Marketwired April 4, 2014

Rosetta Genomics to Receive U.S. Patent for Cancer Origin Assay

eTeligis April 4, 2014

Rosetta Genomics and Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based Diagnostics and Therapeutics for Rare Diseases

Marketwired April 2, 2014

Rosetta Genomics and Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based Diagnostics and Therapeutics for Rare Diseases

Marketwired April 2, 2014

Rosetta Genomics Reports 2013 Financial Results

Marketwired March 31, 2014

Rosetta Genomics Reports 2013 Financial Results

Marketwired March 31, 2014

Rosetta Genomics to Host Business Update Conference Call on April 1, 2014

Marketwired March 25, 2014

Rosetta Genomics to Host Business Update Conference Call on April 1, 2014

eTeligis March 25, 2014

Rosetta Genomics Enters Collaboration With Clalit Health Services' Rabin Medical Center for microRNA-Based Assay for Chronic Allograft Dysfunction Following Kidney Transplantation

Marketwired March 24, 2014

Rosetta Genomics Enters Collaboration With Clalit Health Services' Rabin Medical Center for microRNA-Based Assay for Chronic Allograft Dysfunction Following Kidney Transplantation

eTeligis March 24, 2014

Rosetta Genomics' Cancer Origin Test Highlighted at Landmark CUP Foundation Seminar 2014

eTeligis March 21, 2014

Rosetta Genomics Provides Product Pipeline Update

eTeligis March 12, 2014